These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19783991)

  • 1. Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
    Pathania R; Zlitni S; Barker C; Das R; Gerritsma DA; Lebert J; Awuah E; Melacini G; Capretta FA; Brown ED
    Nat Chem Biol; 2009 Nov; 5(11):849-56. PubMed ID: 19783991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
    Barker CA; Allison SE; Zlitni S; Nguyen ND; Das R; Melacini G; Capretta AA; Brown ED
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2426-31. PubMed ID: 23473681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical biology-whole genome engineering datasets predict new antibacterial combinations.
    Turner AK; Yasir M; Bastkowski S; Telatin A; Page A; Webber M; Charles I
    Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34874820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the permeability of Escherichia coli using MAC13243.
    Muheim C; Götzke H; Eriksson AU; Lindberg S; Lauritsen I; Nørholm MHH; Daley DO
    Sci Rep; 2017 Dec; 7(1):17629. PubMed ID: 29247166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.
    Tomich AD; Klontz EH; Deredge D; Barnard JP; McElheny CL; Eshbach ML; Weisz OA; Wintrode P; Doi Y; Sundberg EJ; Sluis-Cremer N
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analyses of the in vivo function of LolA, a periplasmic chaperone involved in the outer membrane localization of Escherichia coli lipoproteins.
    Tajima T; Yokota N; Matsuyama S; Tokuda H
    FEBS Lett; 1998 Nov; 439(1-2):51-4. PubMed ID: 9849875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Responses of Pseudomonas aeruginosa to Inhibition of Lipoprotein Transport by a Small Molecule Inhibitor.
    Lorenz C; Dougherty TJ; Lory S
    J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32989085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of NlpE overproduction on multidrug resistance in Escherichia coli.
    Nishino K; Yamasaki S; Hayashi-Nishino M; Yamaguchi A
    Antimicrob Agents Chemother; 2010 May; 54(5):2239-43. PubMed ID: 20211889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
    Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
    J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ORF1 gene located on the class-1-integron-associated gene cassette actually represents a novel fosfomycin resistance determinant.
    Yatsuyanagi J; Saito S; Konno T; Harata S; Suzuki N; Amano K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2573. PubMed ID: 15917578
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural investigation of the interaction between LolA and LolB using NMR.
    Nakada S; Sakakura M; Takahashi H; Okuda S; Tokuda H; Shimada I
    J Biol Chem; 2009 Sep; 284(36):24634-43. PubMed ID: 19546215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the LolA-LolB system as the general lipoprotein localization mechanism of Escherichia coli.
    Yokota N; Kuroda T; Matsuyama S; Tokuda H
    J Biol Chem; 1999 Oct; 274(43):30995-9. PubMed ID: 10521496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli.
    Ruiz C; Levy SB
    Antimicrob Agents Chemother; 2010 May; 54(5):2125-34. PubMed ID: 20211899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms.
    Rodríguez-Martínez JM; Ballesta S; Pascual A
    Int J Antimicrob Agents; 2007 Oct; 30(4):366-8. PubMed ID: 17616359
    [No Abstract]   [Full Text] [Related]  

  • 16. Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.
    Aelenei P; Rimbu CM; Guguianu E; Dimitriu G; Aprotosoaie AC; Brebu M; Horhogea CE; Miron A
    Lett Appl Microbiol; 2019 Feb; 68(2):156-164. PubMed ID: 30471142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new screening method to identify inhibitors of the Lol (localization of lipoproteins) system, a novel antibacterial target.
    Ito H; Ura A; Oyamada Y; Yoshida H; Yamagishi J; Narita S; Matsuyama S; Tokuda H
    Microbiol Immunol; 2007; 51(3):263-70. PubMed ID: 17380045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.
    Pan AJ; Mei Q; Ye Y; Li HR; Liu B; Li JB
    J Antibiot (Tokyo); 2017 Feb; 70(2):166-173. PubMed ID: 27756910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa.
    Mine T; Morita Y; Kataoka A; Mizushima T; Tsuchiya T
    Antimicrob Agents Chemother; 1999 Feb; 43(2):415-7. PubMed ID: 9925549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.